RetinAI
Latest round
- Series B
Last raised
- Oct 2024
Total raised
- $10M
Investors
- 6
About RetinAI
Founded in 2017 and based in Bern, Switzerland, by CEO Carlos Ciller, Sandro Zanet, and Stefanos Apostolopoulos, Ikerian AG, doing business as RetinAI operates as a healthcare technology company that develops products using technologies in machine learning and computer vision for eye care professionals and patients. The company provides software solutions that collect, organize, and analyze health data from the eyes. The company's products include RetinAI Discovery and OmniViewer. In October 2025, EssilorLuxottica, acquired Ikerian AG from b2venture, Eureka-Eurostars, Matterwave Ventures Management, Sanoptis AG, Topcon Healthcare, Verve Ventures, and Zürcher Kantonalbank. RetinAI’s discovery platform supports data collection, processing, and visualization, enabling the analysis of disease progression and treatment outcomes. The platform caters to clinics, hospitals, pharmaceutical companies, and researchers by offering modular and certified AI solutions that handle various data formats. RetinAI also focuses on global collaboration, facilitating data sharing and research across organizations. The company's products include Discovery® Unity, Discovery® for clinical studies, and Discovery® for clinics, which provide AI-driven insights and support for clinical workflows and patient management.5 each. October 2025, acquisition enables Ikerian AG (RetinAI) to accelerate global deployment of its AI-driven retinal imaging and clinical-decision solutions by leveraging EssilorLuxottica’s scale, distribution, and technology ecosystem.
Who invested in RetinAI
6 investors across 4 rounds
See all investors in RetinAI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RetinAI
Who invested in RetinAI?
RetinAI has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RetinAI raised?
RetinAI has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did RetinAI last raise money?
RetinAI's most recent round on record is a Series B, in Oct 2024.
What does RetinAI do?
Founded in 2017 and based in Bern, Switzerland, by CEO Carlos Ciller, Sandro Zanet, and Stefanos Apostolopoulos, Ikerian AG, doing business as RetinAI operates as a healthcare technology company that develops products using technologies in machine learning and computer vision for eye care professionals and patients.
Where is RetinAI headquartered?
RetinAI is headquartered in Bern, Switzerland.
Which VCs invest in companies like RetinAI?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back healthcare it companies at RetinAI's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like RetinAI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.